Kansas 2025-2026 Regular Session

Kansas House Bill HB2694

Introduced
2/4/26  

Caption

Enacting the opioid patients right to know act to require the disclosure of the risks associated with prescribed opioid use.

Impact

The introduction of HB 2694 is poised to impact state laws governing opioid prescriptions significantly. By requiring that prescribers discuss the risks involved before issuing the initial prescriptions, healthcare practices in Kansas may become more patient-focused in terms of treatment planning. This act aims to promote responsible opioid prescribing practices, thereby aligning with state efforts to mitigate the opioid crisis. Ensuring that patients or their guardians are fully informed about the implications of opioid use is likely to lead to better healthcare outcomes and reduce the potential for substance misuse over time.

Summary

House Bill 2694, known as the Opioid Patients Right to Know Act, focuses on enhancing transparency and patient awareness regarding the risks associated with prescribed opioid medications. The bill mandates that healthcare providers discuss the potential dangers of opioid use with patients before prescribing any schedule II controlled substances. This includes discussions on risks of addiction, overdose, interactions with other substances, and alternative treatment options that may be available. Such a measure aims to empower patients by providing them with vital information needed to make informed decisions about their treatment options.

Contention

Notably, there may be contention surrounding this bill as it could impose additional burdens on healthcare providers, who might feel the need to allocate extra time for discussions that could lengthen patient appointments. Some healthcare professionals may argue that the time required to adequately discuss these risks could detract from their ability to see more patients, raising concerns over feasibility in busy clinical settings. Moreover, while the bill seeks to enhance patient awareness, opponents might argue that the language for alternatives and risks could be interpreted in various ways, potentially leading to inconsistencies in how information is conveyed to patients.

Companion Bills

No companion bills found.

Similar Bills

No similar bills found.